Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

NCT02432066 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was not started and participants were not enrolled

Conditions

Tobacco Use Disorder

Interventions

DRUG: GTS-21
DRUG: Placebo

Sponsor

University of Florida

Collaborators

[object Object]